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MacroH2A in stem cells: a story beyond gene 
repression
The chromatin of pluripotent cells
In 1938, 5 years before DNA was identified 
as the carrier of genetic information, Conrad 
Waddington had already defined epigenetics as 
the “science concerned with the causal analysis 
of development” [1]. As knowledge about the role 
and structure of chromatin increased, Adrian 
Bird redefined epigenetics as “the structural 
adaptation of chromosomal regions so as to reg-
ister, signal or perpetuate altered activity states” 
[2] due to the fact that such epigenetic mecha-
nisms constitute a level of regulation that can 
translate the same genotype in many different 
phenotypes. The pertinance of this statement is 
illustrated in embryonic development, when a 
single totipotent zygote gives rise to more than 
200 specialized cell types that collectively form 
the embryo. As early embryonic totipotent cells 
divide, they undergo several cell fate transitions 
with progressive loss of differentiation potential 
until they reach their terminally differentiated 
state. It is very important to remember that not 
all cells terminate differentiation at once, in fact, 
all tissues retain a number of specialized stem 
cells with restricted potency that control tissue 
homeostasis and allow wounds to heal during 
adult life.
The genetic content of cells does not usually 
change as cells go through cell fate transitions 
during embryogenesis. Instead, how DNA is 
packed into chromatin and expressed during 
embryonic development and differentiation is 
regulated by epigenetic mechanisms, which are 
important in determining and maintaining cell 
identity. A large body of work has identified 
enzymes that modify chromatin and proteins 
that can read these alterations [3]. Embryonic 
stem (ES) cells, isolated from the inner cell mass 
of the blastocyst, have been extensively used as a 
model to study the molecular basis of epigenetic 
mechanisms. ES cells are pluripotent cells [4]. 
They can self-renew endlessly while retaining 
the ability to differentiate into all somatic cell 
types, which allows researchers to direct them 
into particular lineages using established proto-
cols [5]. The ability to self-renew and to maintain 
the capacity to differentiate into all three germ 
layers is controlled by three transcription fac-
tors: Oct4, Sox2 and Nanog [6–8] that form the 
core of a larger hierarchical transcriptional net-
work [9,10]. In a recursive self-reinforcing circuit 
these core transcription factors maintain their 
expression at a high level in self-renewing ES 
cells. In this state, they directly bind and repress 
differentiation genes [11]. Oct 4 and Nanog are 
downregulated as differentiation programs are 
initiated. On differentiation, chromatin com-
pacts from an initially overall dispersed distribu-
tion into localized dense regions. Early on, this 
observation led to the suggestion that lineage 
specification might be accompanied and per-
haps driven by epigenetic mechanisms that lock 
genes regulating alternative fates into inactive 
c hromatin domains.
A histone variant implicated in 
development
A plethora of post-translational histone modi-
fications occur at the level of the building 
block of chromatin, the nucleosome [12,13]. In 
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combination with direct modification of the 
DNA, primarily cytosine methylation [14], his-
tone modifications provide the molecular puz-
zle pieces of the still incomplete picture of how 
epigenetic mechanisms operate at the molecu-
lar level. The regulated exchange of canonical 
histones for variant proteins further adds to the 
modularity of the nucleosome [15]. Here, we dis-
cuss the role of the histone variant macroH2A in 
early development in light of novel findings in 
mouse ES cells. The current state of knowledge 
about other histone variants has recently been 
reviewed elsewhere [16].
Among all histone variants, macroH2A dif-
fers most from its canonical counterpart since it 
possesses an additional extranucleosomal macro-
domain [17,18]. As such the incorporation of a mac-
roH2A variant can be considered as one of the 
most extensive chromatin alterations occurring 
at the nucleosome level. In the mouse, there are 
two genes: macroH2A1 and macroH2A2. Since 
macroH2A1 can be further alternatively spliced, 
cells can contain three different macroH2A pro-
teins that are distinguished as macroH2A1.1, 
macroH2A1.2 and macroH2A2 [17,19–21]. We 
will point out isoform-specific observations 
whenever possible. But when no distinction can 
be made, we will collectively refer to all three of 
them as macroH2A and to the two splice variants 
as macroH2A1. After fertilization,  macroH2A1 
is evicted from the maternal genome, and 
later, gradually reappears coinciding with the 
moment when cells start l ineage-specification 
after the eight-cell stage [22]. It is interesting to 
note that this expression pattern is maintained 
during early embryogenesis even when mac-
roH2A1 is expressed as a constitutively active 
transgene [23]. It is thought that the absence of 
macroH2A until the eight-cell stage is required 
for normal embryonic development because the 
tethering of macroH2A to chromatin beyond 
this stage by addition of peptide that mediates 
stage-specific H2AX diposition impaired early 
embryogenesis [23].
In ES cells, macroH2A is expressed at moder-
ate levels and its expression increases at differ-
entiation [24,25]. The end points of the differen-
tiation induced upregulation of macroH2A can 
be nicely illustrated by comparing macroH2A1 
levels in mouse ES cells with liver tissue (Figure 1), 
which contains the maximal amount of mac-
roH2A estimated to reach 3% of total H2A 
[26]. In self-renewing E14 mouse ES cells the 
predominantly expressed form of macroH2A is 
macroH2A1.2, which constitutes approximately 
85% of the cellular macroH2A protein [27]. In 
the same cells, macroH2A2 is expressed at much 
lower levels and macroH2A1.1 is undetectable. 
Analysis of more than 40 different established 
human and murine cell lines demonstrated that 
macroH2A1.2 generally tends to be expressed 
at higher levels than macroH2A2 and mac-
roH2A1.1 [Valero V and Buschbeck M, Unpublished 
Data] suggesting that this expression pattern 
is not specific for ES cells but possibly a gen-
eral characteristic of proliferating cells. This 
rule would have at least one exception. Early 
zebrafish embryos exclusively express the mac-
roH2A2 ortholog while macroH2A1 is not 
detected [28]. Knockdown of macroH2A2 in 
zebrafish embryos provoked severe develop-
mental defects, including malformations of the 
body structure and brain [28]. Importantly, some 
of these defects could be rescued by expressing 
human macroH2A2 [28]. This observation pro-
vided the first strong evidence for an important 
role of macroH2A proteins in differentiation and 
developmental processes. This is in contrast to 
the mouse, in which knockout of macroH2A1 
has been reported to display only mild pheno-
types [29,30]. The exciting discrepancy between 
mice and fish could be due to different reasons, 
of which the most intuitive would be a direct 
functional compensation by the remaining 
macroH2A2. Other possible reasons could lie 
in different isoform-specific functions of mac-
roH2A1 and macroH2A2 or in the difference 









Figure 1. MacroH2A levels correlate with the state of differentiation. 
Overview of the macroH2A genes and proteins and their relative expression 
represented by the surface of the circle. Relative expression levels in cells of the 
same species (mouse, human and zebrafish) were determined by quantitative 
RT-PCR using equimolar reference samples [27,28]. Please note that expression levels 
between different species could not be directly compared and were estimated. 
Levels of macroH2A1.1 and macroH2A1.2 in zebrafish were not distinguished. The 
shared macroH2A domain structure is schematically represented (from left to 
right: H2A histone-fold, linker and macrodomain). 
EB: Embryoid body; ES: Embryonic stem cell; PHK: Primary human keratinocyte.
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process, which could allow for compensation by 
alternative mechanisms in the slower developing 
mouse embryo but not in the faster developing 
zebrafish. A wider analysis of loss-of-function 
phenotypes and the identification of operat-
ing compensatory mechanisms will be required 
before we can fully appreciate the extension 
and the limits of macroH2A’s function in 
 developmental regulation.
MacroH2A & the differentiation of 
ES cells
Functional redundancy between macroH2A1 
and macroH2A2 has been proposed as an expla-
nation for the lack of defects in mouse mutant 
embryos. We decided to use E14 mouse ES cells 
that predominantly express macroH2A1.2 to 
approach the function of macroH2A in early 
lineage specification. It is noteworthy that 
shRNA mediated knockdown of macroH2A1 
did not affect ES cell proliferation, survival or 
self-renewal [27,31]. However, differences between 
macroH2A1-deficient and control cells became 
obvious when differentiation was induced using 
three different approaches: neuronal differentia-
tion, multilineage differentiation in embryoid 
bodies and in vivo differentiation in xenografted 
teratomas [27]. Under all three conditions 
 macroH2A1-deficiency partially impaired the 
differentiation capacity of the ES cells. This 
was reflected in the expression level of differen-
tiation genes whose partial inhibition came in 
two flavors: some genes did not reach the nor-
mal amplitude of activation while others were 
delayed. In addition, macroH2A1-deficient ES 
cells retained abnormally high-expression lev-
els of the stem cell markers Nanog, Oct4 and 
Sox2 after prolonged induction of differentiation 
[27]. It is interesting to point out that a similar 
phenotype has also been seen when other well 
established epigenetic regulators such as G9a and 
DNMT3a/b were depleted [32,33].
The commitment defect was also seen in ter-
atomas derived from macroH2A1-knockdown 
cells that displayed a massive expansion of 
undifferentiated carcinoma cells [27]. We con-
clude that macroH2A is required for the proper 
execution of differentiation programs during ES 
cell differentiation. This conclusion differs from 
that obtained by Tansijevic and Rasmussen, 
who reported that double macroH2A1 and 
 macroH2A2 deficiency in ES cells did not pre-
vent X chromosome inactivation and the forma-
tion of embryoid bodies [31]. We believe that this 
discrepancy could be the result of differences 
in genetic background or in the quantitative 
nature and timing of the analyses performed. 
Ultimately, genetic ablation of macroH2As in ES 
cells with different genetic backgrounds will be 
required.
In support of a role of macroH2A in differ-
entiation, macroH2A is rapidly removed from 
chromatin during reprogramming by nuclear 
transfer [34]. A recent study demonstrated the 
relevance of this observation by demonstrating 
that the knockdown of macroH2A in differen-
tiated cells facilitated their reprogramming and 
the reactivation of Oct4 and Sox2 [35]. Gurdon 
et al. noted earlier that different cell types had 
different intrinsic resistance to reprogramming 
by nuclear transfer [36]. Comparing susceptible 
mouse epiblast-derived stem cells with resistant 
embryonic fibroblasts they were able to identify 
macroH2A as one of the epigenetic layers that 
confers resistance to reprogramming [35]. The 
same authors concluded that it is likely that the 
observed resistance directly reflects the stabil-
ity of the differentiated state and that mac-
roH2A contributes to this stability [37]. Taking 
these results together with our observations in 
mouse ES cells, we postulate that macroH2A 
is involved in the establishment of the stable 
epigenomes of differentiated cells as well as 
in their maintenance. In line with this, mac-
roH2A1 levels also correlated with the degree 
of differentiation in human skin sections and 
in multilayered colonies formed by primary 
human keratinocytes [27]. The ability of these 
keratinocytes to form 3D colonies that differ-
entiate from bottom to top can be used to assess 
the number of competent tissue stem cells in the 
heterogeneous primary culture. Overexpression 
of macroH2A1 reduced the number of colony-
forming cells, while shRNA-mediated repres-
sion of macroH2A1 increased it [27]. From these 
observations, we conclude that macroH2A lev-
els modulate the intricate balance between self-
renewal and differentiation not only of ES cells 
but also of adult stem cells.
Is macroH2A also a gene ‘activator’?
The early finding that macroH2A was enriched 
on the inactive X chromosome in female cells 
suggested a repressive function [38]. Subsequently, 
this has been well established in vitro and in vivo 
by a large body of evidence (reviewed in [15,18]). In 
mouse liver chromatin, for instance, macroH2A1 
was found to be depleted from the transcribed 
regions of most active genes [39,40]. Two other 
genome-wide studies later confirmed in other 
cell types that macroH2A occupancy had a 
general negative correlation with transcriptional 
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activity [28,41]. Both studies, however, also pointed 
out that a small number of genes are expressed 
while harboring macroH2A nucleosomes on the 
promoter and/or the transcription start site proxi-
mal transcribed region. Moreover, Gamble et al. 
further demonstrated that macroH2A is required 
for inducible activation of a set of target genes 
[41], thereby corroborating and extending on 
the earlier observation that macroH2A1.1 was 
required for the heat shock-mediated activation 
of Hsp70.1 [42]. In addition, many of the differ-
entiation genes that were not fully activated in 
macroH2A1-deficient ES cells were also enriched 
for macroH2A in undifferentiated cells. This 
suggests that macroH2A could exert a similar 
prosignal sensitivity and proactivation function 
in ES cells [27]. In HeLa cells macroH2A1.1-
specific recruitment of parylated PARP1 and its 
inhibition under normal growth conditions was 
required for maintaining the Hsp70.1 gene sen-
sitive to heat shock [42]. In ES cells, which lack 
macroH2A1.1 the underlying molecular mecha-
nism still remains elusive. But we speculate that 
macroH2A proteins either directly or through 
interacting partners stabilize chromatin states 
that tend to be repressed but at the same time 
are highly sensitive to signal-induced activation. 
This working model reconciles the newly recog-
nized proactivation functions of macroH2A with 
its well established role as repressor.
In ES cells such a chromatin state has been 
well described for many differentiation regulatory 
genes that were termed bivalent genes due to the 
presence of the apparently opposing lysine 4 and 
27 trimethylation marks on histone H3 [43,44]. 
As illustrated in Figure 2, many of the macroH2A 
target genes are marked by ‘opposing’ lysine 4 
and 27 trimethylation marks on histone H3 [27]. 
Interestingly, in self-renewing ES cells loss of mac-
roH2A did not affect the levels of the two bivalent 
lysine methylations on genes that displayed a clear 
defect in their differentiation-induced activation. 
Thus, our data now suggest that macroH2A is 
required for proper functionality of bivalent genes 
without affecting the bivalent signature per se.
How can we put the new knowledge about 
macroH2A into context of what is known 
about the regulation of pluripotency in ES cells? 
Although it is clear that the core transcription 
factors Oct4, Nanog and Sox2 self-sustain their 
expression, it has also been shown that induc-
tion of differentiation genes exerts negative feed-
back on their expression (reviewed in [11]). For 
instance, both Cdx2 and Gata6 were shown to 
directly and indirectly repress the Pou5f1/Oct4 
and Nanog genes. Our data now suggest that 
the presence of macroH2A on prodifferentiation 
genes lowers the threshold for their activation 
and thus, through such a negative feedback loop, 
indirectly contributes to the repression of the core 
transcription factors. Considering the repressive 
potential of macroH2A also provokes the ques-
tion of whether macroH2A could also directly 
contribute to the repression of the pluripotency 
core transcription factors. However, the fact 
that defects in the expression of differentiation 
genes induced by loss of macroH2A1 preceded 
the defective repression of pluripotency genes 
argues against this hypothesis and in favor of 
an indirect mechanism. Even if macroH2A 
might not be required for the establishment of 
the repressed chromatin state on pluripotency 
genes, presently we cannot exclude that it might 
be involved in its maintenance [45], as suggested 
by Pasque et al. [37].
Although macroH2A is a well- characterized 
















Figure 2. MacroH2A interacts with the regulatory circuits of stem cell fate. 
(A) Differentiation genes are marked by macroH2A and bivalent lysine 4 and 
27 methylations on histone H3. This chromatin state keeps regulatory 
differentiation genes repressed but highly sensitive to activating cues. (B) Strongly 
simplified figure illustrating how macroH2A could interfere with the regulatory 
circuits of ES cells. The core pluripotency transcription factors reinforce their own 
expression and repress regulatory differentiation genes. When external signals 
overcome this repression, the products of differentiation genes such as Gata6 and 
Cdx2 contribute to the inactivation of the core transcription factors through direct 
and indirect negative feedback loops, thereby sealing off the cell’s commitment to 
differentiation. The presence of macroH2A on differentiation genes facilitates their 
activation by lowering the activation threshold. For more detailed information on 
how these regulatory circuits work please see the review by Niwa [11]. 
TSS: Transcription start site.
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role in differentiation relies at least partially on 
its much less understood function in signal-
induced gene activation. It will be interesting 
to see whether macroH2A also affects the self-
renewal and differentiation of human ES cells, 
which depend on other signals for self-renewal 
compared with mouse ES cells [46]. Another 
important question is whether the repression 
of macroH2A could help in the generation of 
human induced pluripotent cells for purposes 
of regenerative medicine.
Future perspective
MacroH2A levels correlate with differentiation 
or – if one prefers – inversely correlates with 
cellular potency. Increasing macroH2A levels 
affects the balance between self-renewal and 
differentiation by facilitating the activation of 
its target genes that are part of transcriptional 
differentiation programs. MacroH2A contrib-
utes to the establishment but also the stable 
 maintenance of differentiated phenotypes.
These conclusions are based on the limited 
amount of data available today. Future work 
will be required to test whether these state-
ments prove right in general or only for a 
limited number of plastic cell types and their 
differentiation processes. But it is beyond 
doubt that with the characterization of the 
first physiological functions of macroH2A in 
zebrafish development and ES cell differentia-
tion, research on this unique histone variant has 
reached an exciting turning point. We are now 
in an unique position to analyze the functional 
relevance of its exceptional domain structure 
as well as suggested protein [18] and metabolite 
interactions [47,48]. Virtually nothing is known 
about how the incorporation of macroH2A is 
regulated. In this context it is interesting to 
point that – like most histone – macroH2A 
undergoes several post-translational modifica-
tions [49–51]. Further analysis of the functional 
consequences of these modifications holds 
the promise to provide important clues. It 
is further interesting to point out that mac-
roH2A might have an ambivalent function in 
chromatin condensation. In vitro the linker 
domain of macroH2A is sufficient to mediate 
a histone H1-like condensation of nucleosome 
arrays [52]. However, the presence of the adja-
cent macro domain inhibits this function. This 
suggests that macroH2A-containing chromatin 
might be a metastable form of open chroma-
tin, whose condensation could be induced by 
 factors altering macroH2A protein structure.
Bernstein et al. further fueled the interest in 
macroH2A by showing that its loss contributed 
to the progression of melanoma to the advanced 
and metastatic state [53]. In this context, it is 
interesting to point out that melanoma cells are 
dedifferentiated cells that reactivate embryonic 
signaling pathways [54]. Others could point out 
functional differences between macroH2A1 
splice variants in different types of cancer 
[55,56]. Ongoing and future studies are likely to 
reveal the importance, the regulation and the 
molecular function of macroH2A-containing 
epigenetic mechanisms in a larger number of 
physiological and pathological processes. The 
door is wide open for new discoveries.
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Executive summary
The chromatin of pluripotency
  Embryonic stem (ES) cells are regulated by regulatory circuits of transcription factors.
  ES cells have an open chromatin structure.
A histone variant implicated in development
  MacroH2A is considered a repressive histone variant.
  It is essential for proper zebrafish development.
MacroH2A & the differentiation of ES cells
  MacroH2A levels correlate with the state of differentiation.
  MacroH2A affects the balance between self-renewal and differentiation of ES cells by facilitating lineage commitment.
  MacroH2A contributes to the establishment but also the stable maintenance of differentiated phenotypes.
  In addition to ES cells, macroH2A also regulates the tissue stem cells of the skin.
Is macroH2A also a gene ‘activator’?
  In ES cells, macroH2a targets bivalent differentiation genes and facilitates their activation.
  Thereby, macroH2A influences the regulatory circuits of ES cells.
  This observation provided the physiological relevance of its poorly recognized function in transcriptional activation.
Special RepoRt Creppe, Posavec, Douet & Buschbeck
Epigenomics (2012) 4(2)226 future science group
Financial & competing interests 
disclosure
Research in the Buschbeck laboratory is supported by 
Spanish MICINN grants (SAF2009-08496 and 
RYC2010-07337). C Creppe holds a postdoctoral 
FEBS fellowship, J Douet a postdoctoral Beatriu de 
Pinós contract (AGAUR), M Posavec a predoctoral 
FI fellowship (AGAUR) and M Buschbeck is a 
Ramón Y Cajal fellow (MICINN). The authors 
have no other relevant affiliations or financial 
involvement with any organization or entity with a 
financial interest in or financial conflict with the 
subject matter or materials discussed in the 
manuscript apart from those disclosed.
No writing assistance was utilized in the 
production of this manuscript.
References
Papers of special note have been highlighted as:
n  of interest
nn  of considerable interest
1 Waddington CH. The Epigenetics of Birds. 
Cambridge University Press, Cambridge, UK 
(1952).
2 Bird A. Perceptions of epigenetics. Nature 
447(7143), 396–398 (2007).
3 Bannister AJ, Kouzarides T. Regulation of 
chromatin by histone modifications. Cell Res. 
21(3), 381–395 (2011).
4 Evans M. Discovering pluripotency: 30 years 
of mouse embryonic stem cells. Nat. Rev. Mol. 
Cell Biol. 12(10), 680–686 (2011).
5 Smith AG. Embryo-derived stem cells: of 
mice and men. Annu. Rev. Cell Dev. Biol. 17, 
435–462 (2001).
6 Boyer LA, Lee TI, Cole MF et al. Core 
transcriptional regulatory circuitry in human 
embryonic stem cells. Cell 122(6), 947–956 
(2005).
n	 Leading work among the manuscripts that 
reported the identification of the 
trancriptional circuit that maintains 
pluripotency.
7 Chew JL, Loh YH, Zhang W et al. Reciprocal 
transcriptional regulation of Pou5f1 and Sox2 
via the Oct4/Sox2 complex in embryonic 
stem cells. Mol. Cell Biol. 25(14), 6031–6046 
(2005).
8 Loh YH, Wu Q, Chew JL et al. The Oct4 and 
Nanog transcription network regulates 
pluripotency in mouse embryonic stem cells. 
Nat. Genet. 38(4), 431–440 (2006).
9 Chen X, Xu H, Yuan P et al. Integration of 
external signaling pathways with the core 
transcriptional network in embryonic stem 
cells. Cell 133(6), 1106–1117 (2008).
10 Kim J, Chu J, Shen X, Wang J, Orkin SH. An 
extended transcriptional network for 
pluripotency of embryonic stem cells. Cell 
132(6), 1049–1061 (2008).
11 Niwa H. How is pluripotency determined and 
maintained? Development 134(4), 635–646 
(2007).
12 Hake SB, Xiao A, Allis CD. Linking the 
epigenetic ‘language’ of covalent histone 
modifications to cancer. Br. J. Cancer 
96(Suppl.), R31–R39 (2007).
13 Kouzarides T. Chromatin modifications and 
their function. Cell 128(4), 693–705 (2007).
14 Williams K, Christensen J, Helin K. DNA 
methylation: TET proteins-guardians of CpG 
islands? EMBO Rep. 13(1), 28–35 (2011).
15 Boulard M, Bouvet P, Kundu TK, Dimitrov 
S. Histone variant nucleosomes: structure, 
function and implication in disease. Subcell 
Biochem. 41, 71–89 (2007).
16 Banaszynski LA, Allis CD, Lewis PW. 
Histone variants in metazoan development. 
Dev. Cell 19(5), 662–674 (2011).
17 Pehrson JR, Fried VA. MacroH2A, a core 
histone containing a large nonhistone region. 
Science 257(5075), 1398–1400 (1992).
18 Buschbeck M, Di Croce L. Approaching the 
molecular and physiological function of 
macroH2A variants. Epigenetics 5(2), 
118–123 (2010).
19 Rasmussen TP, Huang T, Mastrangelo MA, 
Loring J, Panning B, Jaenisch R. Messenger 
RNAs encoding mouse histone macroH2A1 
isoforms are expressed at similar levels in male 
and female cells and result from alternative 
splicing. Nucleic Acids Res. 27(18), 
3685–3689 (1999).
20 Chadwick BP, Willard HF. Histone H2A 
variants and the inactive X chromosome: 
identification of a second macroH2A variant. 
Hum. Mol. Genet. 10(10), 1101–1113 (2001).
21 Costanzi C, Pehrson JR. MACROH2A2, a 
new member of the MARCOH2A core 
histone family. J. Biol. Chem. 276(24), 
21776–21784 (2001).
22 Chang CC, Ma Y, Jacobs S, Tian XC, Yang 
X, Rasmussen TP. A maternal store of 
macroH2A is removed from pronuclei prior to 
onset of somatic macroH2A expression in 
preimplantation embryos. Dev. Biol. 278(2), 
367–380 (2005).
23 Nashun B, Yukawa M, Liu H, Akiyama T, 
Aoki F. Changes in the nuclear deposition of 
histone H2A variants during pre-implantation 
development in mice. Development 137(22), 
3785–3794 (2010).
n	 Provides evidence that a tight regulation of 
macroH2A levels is essential at the 
premorula stage of early development.
24 Pehrson JR, Costanzi C, Dharia C. 
Developmental and tissue expression patterns 
of histone macroH2A1 subtypes. J. Cell 
Biochem. 65(1), 107–113 (1997).
25 Dai B, Rasmussen TP. Global epiproteomic 
signatures distinguish embryonic stem cells 
from differentiated cells. Stem Cells 25(10), 
2567–2574 (2007).
26 Mietton F, Sengupta AK, Molla A et al. Weak 
but uniform enrichment of the histone variant 
macroH2A1 along the inactive 
X chromosome. Mol. Cell Biol. 29(1), 
150–156 (2009).
27 Creppe C, Janich P, Cantariño N et al. 
MacroH2A regulates the commitment to 
differentiation of embryonic and adult stem 
cells. Mol. Cell Biol. doi:10.1128/
MCB.06323-11 (2012) (Epub ahead of print).
nn	 Demonstrates that the proactivating 
function of macroH2A contributes to the 
regulation of embryonic stem cell 
differentiation.
28 Buschbeck M, Uribesalgo I, Wibowo I et al. 
The histone variant macroH2A is an 
epigenetic regulator of key developmental 
genes. Nat. Struct. Mol. Biol. 16(10), 
1074–1079 (2009).
nn	 This study provided the first proof for a role 
of macroH2A in development and 
differentiation.
29 Changolkar LN, Costanzi C, Leu NA, Chen 
D, McLaughlin KJ, Pehrson JR. 
Developmental changes in histone 
macroH2A1-mediated gene regulation. Mol. 
Cell Biol. 27(7), 2758–2764 (2007).
n	 Together with [30], this work provides the 
description of the metabolic phenotype of 
macroH2A1-deficient mice.
30 Boulard M, Storck S, Cong R, Pinto R, 
Delage H, Bouvet P. Histone variant 
macroH2A1 deletion in mice causes 
female-specific steatosis. Epigenetics 
Chromatin 3(1), 8 (2010).
n	 Together with [29], this work provides the 
description of the metabolic phenotype of 
macroH2A1-deficient mice.
31 Tanasijevic B, Rasmussen TP. X chromosome 
inactivation and differentiation occur readily 
in ES cells doubly-deficient for macroH2A1 
and macroH2A2. PLoS ONE 6(6), e21512 
(2011).
32 Epsztejn-Litman S, Feldman N, Abu-
Remaileh M et al. De novo DNA methylation 
promoted by G9a prevents reprogramming of 
embryonically silenced genes. Nat. Struct. 
Mol. Biol. 15(11), 1176–1183 (2008).
33 Feldman N, Gerson A, Fang J et al. 
G9a-mediated irreversible epigenetic 
inactivation of Oct-3/4 during early 
embryogenesis. Nat. Cell Biol. 8(2), 188–194 
(2006).
Special RepoRt Creppe, Posavec, Douet & Buschbeck
www.futuremedicine.com 227future science group
MacroH2A & embryonic stem cell fate Special RepoRt
34 Chang CC, Gao S, Sung LY et al. Rapid 
elimination of the histone variant MacroH2A 
from somatic cell heterochromatin after 
nuclear transfer. Cell Reprogram. 12(1), 43–53 
(2010).
35 Pasque V, Gillich A, Garrett N, Gurdon JB. 
Histone variant macroH2A confers resistance 
to nuclear reprogramming. EMBO J. 30(12), 
2373–2387 (2011).
nn	 Demonstrates that macroH2A maintains 
differentiated states and constitutes a layer 
of resistance to reprogramming.
36 Pasque V, Jullien J, Miyamoto K, Halley-Stott 
RP, Gurdon JB. Epigenetic factors influencing 
resistance to nuclear reprogramming. Trends 
Genet. 27(12), 516–525 (2011).
37 Pasque V, Halley-Stott RP, Gillich A, Garrett 
N, Gurdon JB. Epigenetic stability of repressed 
states involving the histone variant macroH2A 
revealed by nuclear transfer to xenopus 
oocytes. Nucleus 2(6), 533–539 (2011).
38 Costanzi C, Pehrson JR. Histone macroH2A1 
is concentrated in the inactive X chromosome 
of female mammals. Nature 393(6685), 
599–601 (1998).
39 Changolkar LN, Pehrson JR. 
macroH2A1 histone variants are depleted on 
active genes but concentrated on the inactive 
X chromosome. Mol. Cell Biol. 26(12), 
4410–4420 (2006).
40 Changolkar LN, Singh G, Cui K et al. 
Genome-wide distribution of 
macroH2A1 histone variants in mouse liver 
chromatin. Mol. Cell Biol. 30(23), 
5473–5483 (2010).
41 Gamble MJ, Frizzell KM, Yang C, 
Krishnakumar R, Kraus WI. The histone 
variant macroH2A1 marks repressed 
autosomal chromatin, but protects a subset of 
its target genes from silencing. Genes Dev. 
24(1), 21–32 (2010).
n	 Together with [42], this article broke the 
dogma of macroH2A as a sole repressor.
42 Ouararhni K, Hadj-Slimane R, Ait-Si-Ali S 
et al. The histone variant mH2A1.1 interferes 
with transcription by down-regulating 
PARP-1 enzymatic activity. Genes Dev. 
20(23), 3324–3336 (2006).
n	 Together with [41], this article broke the 
dogma of macroH2A as a sole repressor.
43 Azuara V, Perry P, Sauer S et al. Chromatin 
signatures of pluripotent cell lines. Nat. Cell 
Biol. 8(5), 532–538 (2006).
44 Bernstein BE, Mikkelsen TS, Xie X et al. A 
bivalent chromatin structure marks key 
developmental genes in embryonic stem cells. 
Cell 125(2), 315–326 (2006).
45 Heard E. Delving into the diversity of 
facultative heterochromatin: the epigenetics 
of the inactive X chromosome. Curr. Opin. 
Genet. Dev. 15(5), 482–489 (2005).
46 Silva J, Smith A. Capturing pluripotency. Cell 
132(4), 532–536 (2008).
n	 Short review raising and discussing some of 
the most essential questions in embryonic 
stem cell biology.
47 Kustatscher G, Hothorn M, Pugieux C, 
Scheffzek K, Ladurner AG. Splicing regulates 
NAD metabolite binding to histone 
macroH2A. Nat. Struct. Mol. Biol. 12(7), 
624–625 (2005).
48 Timinszky G, Till S, Hassa PO et al. A 
macrodomain-containing histone rearranges 
chromatin upon sensing PARP1 activation. 
Nat. Struct. Mol. Biol. 16(9), 923–929 (2009).
49 Bernstein E, Muratore-Schroeder TL, Diaz 
RL et al. A phosphorylated subpopulation of 
the histone variant macroH2A1 is excluded 
from the inactive X chromosome and 
enriched during mitosis. Proc. Natl Acad. Sci. 
USA 105(5), 1533–1538 (2008).
50 Abbott DW, Chadwick BP, Thambirajah AA, 
Ausio J. Beyond the Xi: macroH2A 
chromatin distribution and post-translational 
modification in an avian system. J. Biol. 
Chem. 280(16), 16437–16445 (2005).
51 Thambirajah AA, Li A, Ishibashi T, Ausio J. 
New developments in post-translational 
modifications and functions of histone H2A 
variants. Biochem. Cell Biol. 87(1), 7–17 
(2009).
52 Muthurajan UM, McBryant SJ, Lu X, 
Hansen JC, Luger K. The linker region of 
macroH2A promotes self-association of 
nucleosomal arrays. J. Biol. Chem. 286(27), 
23852–23864 (2011).
53 Kapoor A, Goldberg MS, Cumberland LK 
et al. The histone variant macroH2A 
suppresses melanoma progression through 
regulation of CDK8. Nature 468(7327), 
1105–1109 (2010).
nn	 Delivered the first proof that loss of 
macroH2A is involved in cancer progression.
54 Strizzi L, Hardy KM, Kirsammer GT, 
Gerami P, Hendrix MJ. Embryonic signaling 
in melanoma: potential for diagnosis and 
therapy. Lab. Invest. 91(6), 819–824 (2011).
55 Novikov L, Park JW, Chen H, Klerman H, 
Jalloh AS, Gamble MJ. QKI-mediated 
alternative splicing of the histone variant 
macroH2A1 regulates cancer cell proliferation. 
Mol. Cell Biol. 31(20), 4244–4255 (2011).
56 Sporn JC, Kustatscher G, Hothorn T et al. 
Histone macroH2A isoforms predict the risk 
of lung cancer recurrence. Oncogene 28(38), 
3423–3428 (2009).
